2.12
price down icon7.63%   -0.175
after-market Dopo l'orario di chiusura: 2.14 0.02 +0.94%
loading
Precedente Chiudi:
$2.295
Aprire:
$2.22
Volume 24 ore:
83,278
Relative Volume:
0.07
Capitalizzazione di mercato:
$14.48M
Reddito:
-
Utile/perdita netta:
$-19.54M
Rapporto P/E:
-1.6219
EPS:
-1.3071
Flusso di cassa netto:
$-21.18M
1 W Prestazione:
-3.64%
1M Prestazione:
+221.70%
6M Prestazione:
+214.07%
1 anno Prestazione:
-39.26%
Intervallo 1D:
Value
$2.07
$2.29
Intervallo di 1 settimana:
Value
$1.91
$2.31
Portata 52W:
Value
$0.44
$7.20

Calcimedica Inc Stock (CALC) Company Profile

Name
Nome
Calcimedica Inc
Name
Telefono
858-952-5500
Name
Indirizzo
505 COAST BOULEVARD SOUTH, LA JOLLA
Name
Dipendente
16
Name
Cinguettio
Name
Prossima data di guadagno
2026-08-11
Name
Ultimi documenti SEC
Name
CALC's Discussions on Twitter

Compare CALC vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
CALC icon
CALC
Calcimedica Inc
2.12 15.67M 0 -19.54M -21.18M -1.3071
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
514.56 132.08B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
793.26 83.15B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
984.04 62.71B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
136.62 54.14B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
203.35 44.51B 742.00K -1.37B -1.07B -7.0731

Calcimedica Inc Stock (CALC) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-01-29 Downgrade H.C. Wainwright Buy → Neutral

Calcimedica Inc Borsa (CALC) Ultime notizie

pulisher
Sep 08, 2026

Investors can meet CalciMedica on Sept. 15 - Stock Titan

Sep 08, 2026
pulisher
Sep 07, 2026

CalciMedica, Inc. (CALC) Stock Price & News - Syfe

Sep 07, 2026
pulisher
Sep 02, 2026

CalciMedica Addresses Nasdaq Equity Compliance Amid Bid-Price Risk - TipRanks

Sep 02, 2026
pulisher
Sep 02, 2026

CalciMedica (NASDAQ: CALC) fixes one Nasdaq warning but faces a $1 price deadline - Stock Titan

Sep 02, 2026
pulisher
Aug 31, 2026

Stonepine Capital Management Expands CalciMedica Stake in Bold Contrarian Move - GuruFocus

Aug 31, 2026
pulisher
Aug 31, 2026

CALC Q2 2026 Earnings: Wider-Than-Expected Loss Sends Shares Down 7.84%Tax Rate Impact - vinanet.vn

Aug 31, 2026
pulisher
Aug 27, 2026

CalciMedica To Carry Out 1-for-5 Reverse Stock Split On August 31st, 2026 - Moomoo

Aug 27, 2026
pulisher
Aug 27, 2026

CalciMedica executes 1-for-5 reverse stock split By Investing.com - Investing.com South Africa

Aug 27, 2026
pulisher
Aug 27, 2026

CalciMedica executes 1-for-5 reverse stock split - Investing.com

Aug 27, 2026
pulisher
Aug 27, 2026

CalciMedica Announces One-for-Five Reverse Stock Split - marketscreener.com

Aug 27, 2026
pulisher
Aug 26, 2026

CalciMedica (CALC) Quarter in Focus: The Available Earnings Metric Delivers a Beat; Closing Move: Shares Move Higher 5.68% for the Current SessionROA Comparison - dars.gov.et

Aug 26, 2026
pulisher
Aug 25, 2026

Stonepine takes CalciMedica (CALC) stake via capped warrants - Stock Titan

Aug 25, 2026
pulisher
Aug 24, 2026

Alafi Capital updates CalciMedica (NASDAQ: CALC) stake after multimillion-warrant grant - stocktitan.net

Aug 24, 2026
pulisher
Aug 21, 2026

CalciMedica (CALC) grants director 10,000 stock options through 2036 - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (NASDAQ: CALC) awards director 10,000 options at $0.61 - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (CALC) grants director 10,000 stock options at $0.61 - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (CALC) director granted 2.9M-share warrants with 9.99% cap - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (NASDAQ: CALC) grants FDA-linked warrants capped at 19.99% stake - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (NASDAQ: CALC) CEO granted new stock warrants - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (NASDAQ: CALC) has 9.99% holder blocked from using more warrants - Stock Titan

Aug 21, 2026
pulisher
Aug 21, 2026

CalciMedica (CALC) Financial Update: EPS Lands Above Forecast in the Current Update; The Stock Ends Down 4.88% in the Current UpdateProfit Inflection Point - vinanet.vn

Aug 21, 2026
pulisher
Aug 20, 2026

ARMISTICE CAPITAL, LLC Acquires Significant Stake in CalciMedica Inc (CALC) - GuruFocus

Aug 20, 2026
pulisher
Aug 20, 2026

CalciMedica Shareholders Approve Reverse Stock Split - Minichart

Aug 20, 2026
pulisher
Aug 20, 2026

CalciMedica Shareholders Approve Key Equity and Governance Changes - TipRanks

Aug 20, 2026
pulisher
Aug 20, 2026

CalciMedica (NASDAQ: CALC) holders back reverse split and warrant deals - Stock Titan

Aug 20, 2026
pulisher
Aug 20, 2026

Guggenheim initiates CalciMedica stock with buy rating on drug potential - Investing.com

Aug 20, 2026
pulisher
Aug 20, 2026

Guggenheim initiates CalciMedica stock coverage with buy rating By Investing.com - Investing.com India

Aug 20, 2026
pulisher
Aug 14, 2026

CalciMedica (CALC) Edges Higher by 2.71% as Shares Consolidate Between $0.65 and $0.71TRIN Signal - dars.gov.et

Aug 14, 2026
pulisher
Aug 14, 2026

Woodline Partners discloses 8.1% CalciMedica (CALC) stake and sole voting power - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

Armistice Capital (CALC) discloses 3.41M-share, 9.99% holding in CalciMedica - Stock Titan

Aug 14, 2026
pulisher
Aug 14, 2026

CALC Q1 2026 Earnings: EPS of $0.30 Crushes Estimates, Stock Advances 6%Revenue Miss Report - vinanet.vn

Aug 14, 2026
pulisher
Aug 13, 2026

CALC Q1 2026 Earnings: EPS Swings to Profit With 205.04% SurpriseEarnings Sentiment Score - vinanet.vn

Aug 13, 2026
pulisher
Aug 13, 2026

CalciMedica shares see H.C. Wainwright neutral rating reiterated - Investing.com

Aug 13, 2026
pulisher
Aug 13, 2026

CalciMedica shares see H.C. Wainwright neutral rating reiterated By Investing.com - Investing.com Canada

Aug 13, 2026
pulisher
Aug 13, 2026

Price to book forward of CalciMedica, Inc. – NASDAQ:CALC - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Price to book forward of CalciMedica, Inc. – BOATS:CALC - tradingview.com

Aug 13, 2026
pulisher
Aug 13, 2026

Price to sales forward of CalciMedica, Inc. – NASDAQ:CALC - tradingview.com

Aug 13, 2026
pulisher
Aug 13, 2026

Price to sales forward of CalciMedica, Inc. – BOATS:CALC - TradingView

Aug 13, 2026
pulisher
Aug 12, 2026

CalciMedica Inc (CALC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 12, 2026
pulisher
Aug 11, 2026

Form 8K CalciMedica Inc For: 11 August By Investing.com - Investing.com UK

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica, Inc. 2Q 2026: Net loss $7.7M, EPS $(0.45) — 10-Q Summary - TradingView

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica (CALC) cuts expenses, raises $15M but flags going concern risk - Stock Titan

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica Releases Q2 2026 Financial Results - AlphaStreet

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica stock gains 6% as pulmonary hypertension progress offsets Q2 earnings miss - Yahoo Finance

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica Secures Up To $49 Million Private Placement To Advance Pulmonary Hypertension Pipeline - Minichart

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica Q2 FY26 net loss widens to $7.65 million - Bitget

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica stock gains 6% despite earnings miss on pulmonary trial By Investing.com - Investing.com South Africa

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica stock gains 6% despite earnings miss on pulmonary trial - Investing.com

Aug 11, 2026
pulisher
Aug 11, 2026

CalciMedica reports Q2 2026 results: $18.6M cash, net loss $7.7M; financing to fund PH programs - TradingView

Aug 11, 2026

Calcimedica Inc Azioni (CALC) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):